Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Marcucci

Showing results (201-210 of 536) with videos related to

Pageof 54
Sort By:
Blood|February 27, 2015
Decitabine priming enhances the antileukemic effects of exportin 1 (XPO1) selective inhibitor selinexor in acute myeloid leukemiaParvathi Ranganathan, Xueyan Yu, Ramasamy Santhanam, et al.
The Journal of Clinical Investigation|June 6, 2025
CAR-T cells targeting CD155 reduce tumor burden in preclinical models of leukemia and solid tumorsTianchen Xiong, Ge Wang, Peng Yu, et al.
The AAPS Journal|July 14, 2010
A novel ultrasensitive hybridization-based ELISA method for 2-methoxyphosphorothiolate microRNAs and its in vitro and in vivo applicationKenneth K Chan, Zhongfa Liu, Zhiliang Xie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2006
Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B StudyPeter Paschka, Guido Marcucci, Amy S Ruppert, et al.
NPJ Systems Biology and Applications|March 20, 2026
Overcoming vascular niche-mediated TKI resistance in acute myeloid leukemia through miR-126 inhibitionMatthew Froid, Sergio Branciamore, Ziang Chen, et al.
Leukemia & Lymphoma|April 17, 2024
Flotetuzumab as a salvage immunotherapy in advanced CD123-positive hematological malignancies, a phase 1 pilot studyIbrahim Aldoss, Jianying Zhang, Marjorie Robbins, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 22, 2006
MicroRNA fingerprints during human megakaryocytopoiesisRamiro Garzon, Flavia Pichiorri, Tiziana Palumbo, et al.
Leukemia & Lymphoma|December 22, 2012
Pharmacokinetics and dose escalation of the heat shock protein inhibitor 17-allyamino-17-demethoxygeldanamycin in combination with bortezomib in relapsed or refractory acute myeloid leukemiaAlison R Walker, Rebecca Klisovic, Jeffrey S Johnston, et al.
Haematologica|October 1, 2013
Autologous transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia achieves outcomes similar to allogeneic transplantation: results of CALGB Study 10001 (Alliance)Meir Wetzler, Dorothy Watson, Wendy Stock, et al.
British Journal of Clinical Pharmacology|January 24, 2019
Population pharmacokinetics of lenalidomide in patients with B-cell malignanciesJim H Hughes, Mitch A Phelps, Richard N Upton, et al.
Pageof 54

Showing results (201-210 of 536) with videos related to

Sort By:
Pageof 54
Blood|February 27, 2015
Decitabine priming enhances the antileukemic effects of exportin 1 (XPO1) selective inhibitor selinexor in acute myeloid leukemiaParvathi Ranganathan, Xueyan Yu, Ramasamy Santhanam, et al.
The Journal of Clinical Investigation|June 6, 2025
CAR-T cells targeting CD155 reduce tumor burden in preclinical models of leukemia and solid tumorsTianchen Xiong, Ge Wang, Peng Yu, et al.
The AAPS Journal|July 14, 2010
A novel ultrasensitive hybridization-based ELISA method for 2-methoxyphosphorothiolate microRNAs and its in vitro and in vivo applicationKenneth K Chan, Zhongfa Liu, Zhiliang Xie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2006
Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B StudyPeter Paschka, Guido Marcucci, Amy S Ruppert, et al.
NPJ Systems Biology and Applications|March 20, 2026
Overcoming vascular niche-mediated TKI resistance in acute myeloid leukemia through miR-126 inhibitionMatthew Froid, Sergio Branciamore, Ziang Chen, et al.
Leukemia & Lymphoma|April 17, 2024
Flotetuzumab as a salvage immunotherapy in advanced CD123-positive hematological malignancies, a phase 1 pilot studyIbrahim Aldoss, Jianying Zhang, Marjorie Robbins, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 22, 2006
MicroRNA fingerprints during human megakaryocytopoiesisRamiro Garzon, Flavia Pichiorri, Tiziana Palumbo, et al.
Leukemia & Lymphoma|December 22, 2012
Pharmacokinetics and dose escalation of the heat shock protein inhibitor 17-allyamino-17-demethoxygeldanamycin in combination with bortezomib in relapsed or refractory acute myeloid leukemiaAlison R Walker, Rebecca Klisovic, Jeffrey S Johnston, et al.
Haematologica|October 1, 2013
Autologous transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia achieves outcomes similar to allogeneic transplantation: results of CALGB Study 10001 (Alliance)Meir Wetzler, Dorothy Watson, Wendy Stock, et al.
British Journal of Clinical Pharmacology|January 24, 2019
Population pharmacokinetics of lenalidomide in patients with B-cell malignanciesJim H Hughes, Mitch A Phelps, Richard N Upton, et al.
Pageof 54